# Medtronic RevElution Trial

Study · id `cardio:ct-nct02480348` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02480348](<https://clinicaltrials.gov/study/NCT02480348>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02480348

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.

## Technical summary

Registry record NCT02480348. Allocation not applicable; no masking; primary purpose treatment. Start 2015-12-03 (actual); primary completion 2017-06-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 109 participants (enrolled count; ClinicalTrials.gov record NCT02480348, source copy `cardio:ctgov-nct02480348-2020-07-07`, retrieved 2026-10-26)
- Started: 2015-12-03 (actual) (ClinicalTrials.gov record NCT02480348, source copy `cardio:ctgov-nct02480348-2020-07-07`, retrieved 2026-10-26)
- Primary completion: 2017-06-16 (actual) (ClinicalTrials.gov record NCT02480348, source copy `cardio:ctgov-nct02480348-2020-07-07`, retrieved 2026-10-26)
- Completion: 2019-10-21 (actual) (ClinicalTrials.gov record NCT02480348, source copy `cardio:ctgov-nct02480348-2020-07-07`, retrieved 2026-10-26)
- Countries: Australia; Brazil; Singapore (ClinicalTrials.gov record NCT02480348, source copy `cardio:ctgov-nct02480348-2020-07-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02480348-2020-07-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Medtronic RevElution Trial
- Acronym: RevElution
- Condition: Coronary Artery Disease
- Intervention (Device): Polymer-free DES (Drug Eluting Stent)
- Lead sponsor: Medtronic Vascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Medtronic Vascular (`cardio:org-medtronic-vascular`)

## Provenance

Content hash: 3089a03d6b00be36643f2709838288b2479cc390dfca58bb056ed41ce4630556
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
